Reduction of cephalic arteriovenous shunting by ergotamine is not mediated by 5-HT1-like or 5-HT2 receptors.

1. The potent, antimigraine drug ergotamine has affinity for both 5-HT1 and 5-HT2 binding sites and constricts arteriovenous anastomoses. Since 5-HT also constricts arteriovenous anastomoses (mainly via 5-HT1-like receptors), this study investigates the involvement of 5-HT receptors in the ergotamin...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bom, A. H., Heiligers, J. P., Saxena, P. R., Verdouw, P. D.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 1989
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1854530/
https://ncbi.nlm.nih.gov/pubmed/2758221
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak